{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:02:54Z","timestamp":1781712174534,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["JPMH20FC1025"],"award-info":[{"award-number":["JPMH20FC1025"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20ek0109482"],"award-info":[{"award-number":["JP20ek0109482"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17ek0109276"],"award-info":[{"award-number":["JP17ek0109276"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ymgmr.2022.100892","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T05:59:32Z","timestamp":1656655172000},"page":"100892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A case report of two siblings with hypertyrosinemia type 1 presenting with hepatic disease with different onset time and severity"],"prefix":"10.1016","volume":"32","author":[{"given":"Kazuo","family":"Kawabata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanobu","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirou","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimitoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2022.100892_bb0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13023-014-0107-7","article-title":"Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice","volume":"9","author":"Mayorandan","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0010","first-page":"525","article-title":"Cloning and expression of the cDNA encoding human fumarylacetoacetate hydrolase, the enzyme deficient in hereditary tyrosinemia: assignment of the gene to chromosome 15","volume":"48","author":"Phaneuf","year":"1991","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1172-8-8","article-title":"Recommendations for the management of tyrosinaemia type 1","volume":"8","author":"de Laet","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0020","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/gim.2017.101","article-title":"Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations","volume":"19","author":"Chinsky","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0025","first-page":"90","article-title":"Hepatocellular carcinoma in hereditary tyrosinemia type I despite 2-(2 Nitro-4-3 Trifluoro- Methylbenzoyl)-1, 3-cyclohexanedione treatment","volume":"40","author":"van Spronsen","year":"2005","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10545-008-0793-1","article-title":"NTBC treatment in tyrosinaemia type I: long-term outcome in French patients","volume":"31","author":"Masurel-Paulet","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/ped.12550","article-title":"Diagnosis and treatment of hereditary tyrosinemia in Japan","volume":"57","author":"Nakamura","year":"2015","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-277X.2011.01215.x","article-title":"Diurnal variation of phenylalanine concentrations in tyrosinaemia type 1: should we be concerned?","volume":"25","author":"Daly","year":"2012","journal-title":"J. Hum. Nutr. Diet."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1179\/027249304225019000","article-title":"Experience with NTBC therapy in hereditary tyrosinaemia type I: an alternative to liver transplantation","volume":"24","author":"Joshi","year":"2004","journal-title":"Ann. Trop. Paediatr."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13498","article-title":"Live donor liver transplantation for type 1 tyrosinemia: an analysis of 15 patients","volume":"23","author":"Karaca","year":"2019","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/1751-2980.12846","article-title":"Living-donor liver transplantation for children with tyrosinemia type I","volume":"21","author":"Liu","year":"2020","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0060","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1399-3046.2011.01497.x","article-title":"Liver transplantation for hereditary tyrosinemia type I: analysis of the UNOS database","volume":"15","author":"Arnon","year":"2011","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0065","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ymgme.2014.07.021","article-title":"Early effect of NTBC on renal tubular dysfunction in hereditary tyrosinemia type 1","volume":"113","author":"Maiorana","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0070","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10545-014-9683-x","article-title":"Early nitisinone treatment reduces the need for liver transplantation in children with tyrosinaemia type 1 and improves post-transplant renal function","volume":"37","author":"Bartlett","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13023-020-01547-w","article-title":"Type 1 tyrosinemia in Finland: a nationwide study","volume":"15","author":"\u00c4\u00e4rel\u00e4","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13023-016-0472-5","article-title":"Neurocognitive outcome in tyrosinemia type 1 patients compared to healthy controls","volume":"11","author":"van Ginkel","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0085","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10545-011-9394-5","article-title":"Neurocognitive outcome in patients with hypertyrosinemia type I after long-term treatment with NTBC","volume":"35","author":"Thimm","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0090","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jpeds.2013.10.001","article-title":"Impaired cognitive functioning in patients with tyrosinemia type I receiving nitisinone","volume":"164","author":"Bendadi","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0095","first-page":"12","article-title":"Long-term cognitive functioning in individuals with tyrosinemia type 1 treated with nitisinone and protein-restricted diet","volume":"11","author":"Garc\u00eda","year":"2017","journal-title":"Mol. Genet. Metabol. Rep."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/(SICI)1098-1004(1998)12:1<19::AID-HUMU3>3.0.CO;2-3","article-title":"Spectrum of mutations in the fumarylacetoacetate hydrolase gene of tyrosinemia type 1 patients in northwestern Europe and Mediterranean countries","volume":"12","author":"Bergman","year":"1998","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0105","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/humu.9001","article-title":"Mutation analysis of the FAH gene in Israeli patients with tyrosinemia type I","volume":"19","author":"Elpeleg","year":"2002","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0110","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ymgme.2011.06.019","article-title":"Identification of mutations causing hereditary tyrosinemia type I in patients of Middle Eastern origin","volume":"104","author":"Imtiaz","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2022.100892_bb0115","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017303","article-title":"Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain","volume":"98","author":"Couce","year":"2019","journal-title":"Medicine."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426922000520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426922000520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:54:33Z","timestamp":1778860473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426922000520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":23,"alternative-id":["S2214426922000520"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100892","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case report of two siblings with hypertyrosinemia type 1 presenting with hepatic disease with different onset time and severity","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100892"}}